Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 75 articles:
HTML format



Single Articles


    March 2021
  1. HOPPE BS, Advani R, Milgrom SA, Bakst RL, et al
    Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society(TM) Appropriate Use Criteria.
    Int J Radiat Oncol Biol Phys. 2021 Mar 24. pii: S0360-3016(21)00295.
    PubMed     Abstract available


    February 2021
  2. QI SN, Li YX, Specht L, Oguchi M, et al
    Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2021 Feb 10. pii: S0360-3016(21)00186.
    PubMed     Abstract available


    December 2020
  3. MOU E, Advani RH, von Eyben R, Rosenberg SA, et al
    Long-Term Outcomes of Patients with Early-Stage Non-Bulky Hodgkin Lymphoma Treated with Combined Modality Therapy on the Stanford V Trials (The G4 and G5 Studies).
    Int J Radiat Oncol Biol Phys. 2020 Dec 29. pii: S0360-3016(20)34735.
    PubMed     Abstract available


  4. FANG P, Gunther JR, Pinnix CC, Dong W, et al
    A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Dec 9. pii: S0360-3016(20)34644.
    PubMed     Abstract available


  5. SPECHT L, Wong JYC, Filippi AR, Dabaja BS, et al
    In Reply to Scarpelli et al.
    Int J Radiat Oncol Biol Phys. 2020;108:1396.
    PubMed    


  6. SCARPELLI DB, Murphy B, Chang BH, Nemecek E, et al
    In Regard to Wong et al.
    Int J Radiat Oncol Biol Phys. 2020;108:1395-1396.
    PubMed    


    November 2020
  7. PATEL R, Zhang L, Desai A, Hoenerhoff MJ, et al
    Protons and High-Linear Energy Transfer Radiation Induce Genetically Similar Lymphomas With High Penetrance in a Mouse Model of the Aging Human Hematopoietic System.
    Int J Radiat Oncol Biol Phys. 2020;108:1091-1102.
    PubMed     Abstract available


    October 2020
  8. KRISHNAN S, Narayan HK, Freedman G, Plastaras JP, et al
    Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34406.
    PubMed     Abstract available


  9. HARARI PM, Lambert PF
    Life Beyond COVID: Pay Attention to Viruses.
    Int J Radiat Oncol Biol Phys. 2020;108:348-350.
    PubMed    


    August 2020
  10. TSENG YD, Hoppe BS, Dedeckova K, Patel CG, et al
    Risk of pneumonitis and outcomes after mediastinal proton therapy for relapsed/refractory lymphoma: A PTCOG and PCG collaboration.
    Int J Radiat Oncol Biol Phys. 2020 Aug 28. pii: S0360-3016(20)34202.
    PubMed     Abstract available


  11. DABAJA BS, Ng AK, Terezakis SA, Plastaras JP, et al
    ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Aug 4. pii: S0360-3016(20)31365.
    PubMed    


    July 2020
  12. DABAJA B, Milgrom S, Parikh R, Wu S, et al
    The Challenges of Applying Radiation in Primary Central Nervous System Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020;107:398-400.
    PubMed    


  13. TSANG RW, Laperriere N
    Whole Brain Radiation Is Still the Standard in the Salvage Situation.
    Int J Radiat Oncol Biol Phys. 2020;107:403.
    PubMed    


  14. PARIKH RR
    More Is Better, Especially When Radiation Is the Best Option....
    Int J Radiat Oncol Biol Phys. 2020;107:402-403.
    PubMed    


  15. MILGROM SA
    Striking a Delicate Balance: Disease Control Without Neurotoxicity.
    Int J Radiat Oncol Biol Phys. 2020;107:401.
    PubMed    


    May 2020
  16. WRIGHT CM, LaRiviere MJ, Baron JA, Uche C, et al
    Bridging Radiation Therapy Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for relapsed/refractory aggressive B-cell lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 May 21. pii: S0360-3016(20)31138.
    PubMed     Abstract available


  17. PATEL CG, Ng AK
    Involved-Site Radiation Therapy for Early-Stage NLPHL.
    Int J Radiat Oncol Biol Phys. 2020;107:21-22.
    PubMed    


  18. GUNTHER JR
    Involved-Site Radiation Therapy if Minimal Toxicity.
    Int J Radiat Oncol Biol Phys. 2020;107:20-21.
    PubMed    


  19. BUDNIK J, Suri J, Constine LS
    A (Sub)Mental Challenge.
    Int J Radiat Oncol Biol Phys. 2020;107:18-19.
    PubMed    


    April 2020
  20. WIRTH A, Mikhaeel NG, Pauline Aleman BM, Pinnix CC, et al
    Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines.
    Int J Radiat Oncol Biol Phys. 2020 Apr 6. pii: S0360-3016(20)30943.
    PubMed    


    March 2020
  21. BATES JE, Parikh RR, Mendenhall NP, Morris CG, et al
    Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Mar 12. pii: S0360-3016(20)30896.
    PubMed     Abstract available


  22. MACMANUS MP, Hofman MS, Hicks RJ, Campbell BA, et al
    Abscopal Regressions of Lymphoma after Involved-Site Radiotherapy Confirmed by Positron Emission Tomography.
    Int J Radiat Oncol Biol Phys. 2020 Mar 6. pii: S0360-3016(20)30886.
    PubMed     Abstract available


  23. BAKST RL, Campbell BA, Pinnix CC
    PET Guided Therapy for Early Stage Hodgkin Lymphoma - Are We Positive About a Negative Interim Scan?
    Int J Radiat Oncol Biol Phys. 2020 Mar 3. pii: S0360-3016(20)30885.
    PubMed    


  24. SPECHT L
    Cardiac Lymphoma, a Challenging Extranodal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020;106:463.
    PubMed    


  25. KIL WJ
    Shape of the Heart: A 68-Year-Old Man With a Primary Cardiac Non-Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020;106:460-461.
    PubMed    


  26. KELSEY CR
    Excessive Exposure.
    Int J Radiat Oncol Biol Phys. 2020;106:462.
    PubMed    


  27. CAMPBELL BA, Seymour JF
    Safety Is the Heart of the Matter.
    Int J Radiat Oncol Biol Phys. 2020;106:462-463.
    PubMed    


    January 2020
  28. DABAJA B
    Would Negative Interim PET Be Enough to Omit Radiation in Patients With Early Hodgkin Lymphoma? The Answer Is No.
    Int J Radiat Oncol Biol Phys. 2020;106:16-17.
    PubMed    


  29. FARRUGIA MK, Vargo JA
    What to Do With Deauville 3 Interim Positron Emission Tomography/Computed Tomography Response in a Young Woman With Classic Unfavorable Hodgkin's Lymphoma: To Irradiate or Not to Irradiate?
    Int J Radiat Oncol Biol Phys. 2020;106:13-14.
    PubMed    


  30. HOPPE BS
    Follow Your Heart.
    Int J Radiat Oncol Biol Phys. 2020;106:17-18.
    PubMed    


  31. YANG JC, Yahalom J
    Deauville Dubiosity.
    Int J Radiat Oncol Biol Phys. 2020;106:16.
    PubMed    


  32. HOPPE RT
    Keep the Dose Low. Keep the Fields Tight.
    Int J Radiat Oncol Biol Phys. 2020;106:15.
    PubMed    


    September 2019
  33. HOPPE RT
    20 Gy Versus 30 Gy: Will it Make a Difference?
    Int J Radiat Oncol Biol Phys. 2019;105:102-103.
    PubMed    


    June 2019
  34. CAMPBELL BA, Plastaras JP, Savage KJ
    Keeping our finger on the pulse: reaffirming the role of radiotherapy in the curative management of early stage follicular lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Jun 26. pii: S0360-3016(19)33393.
    PubMed    


  35. SIM AJ, Jain MD, Figura N, Chavez JC, et al
    Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Jun 5. pii: S0360-3016(19)30819.
    PubMed     Abstract available


  36. INSKIP PD, Veiga LHS, Brenner AV, Sigurdson AJ, et al
    Hyperthyroidism After Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study.
    Int J Radiat Oncol Biol Phys. 2019;104:415-424.
    PubMed     Abstract available


  37. MITO JK, Mitra D, Barysauskas CM, Marino-Enriquez A, et al
    A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas.
    Int J Radiat Oncol Biol Phys. 2019;104:425-435.
    PubMed     Abstract available


    March 2019
  38. KELSEY CR, Broadwater G, James O, Chino J, et al
    Phase II Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30313.
    PubMed     Abstract available


  39. BINKLEY MS, Brady JL, Hajj C, Chelius M, et al
    Salvage treatment and survival for relapsed follicular lymphoma following primary radiotherapy: A collaborative study on behalf of ILROG.
    Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30317.
    PubMed     Abstract available


    February 2019
  40. PINNIX CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, et al
    Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Feb 12. pii: S0360-3016(19)30192.
    PubMed     Abstract available


  41. MIKHAEEL NG, Milgrom SA, Terezakis S, Berthelsen AK, et al
    The optimal use of imaging in Radiation Therapy for lymphoma - Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).
    Int J Radiat Oncol Biol Phys. 2019 Feb 11. pii: S0360-3016(19)30191.
    PubMed     Abstract available


  42. PAUDEL N, Schulze D, Gentzler RD, Evens AM, et al
    Patterns of Failure and Survival Outcomes After Total Lymphoid Irradiation and High-Dose Chemotherapy With Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Feb 11. pii: S0360-3016(19)30197.
    PubMed     Abstract available


    December 2018
  43. WIRTH A, Prince HM, Roos D, Gibson J, et al
    A prospective, multicentre study of involved-field radiotherapy with autologous stem cell transplantation for patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma (ALLG HDNHL04/TROG 03.03).
    Int J Radiat Oncol Biol Phys. 2018 Dec 13. pii: S0360-3016(18)34123.
    PubMed     Abstract available


    November 2018
  44. DEMISSEI BG, Freedman G, Feigenberg SJ, Plastaras JP, et al
    Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer and lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33999.
    PubMed     Abstract available


  45. DABAJA BS, Specht L, Yahalom J
    Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG).
    Int J Radiat Oncol Biol Phys. 2018;102:508-514.
    PubMed     Abstract available


    October 2018
  46. BAKST RL, Dabaja BS, Specht LK, Yahalom J, et al
    Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;102:314-319.
    PubMed     Abstract available


    September 2018
  47. QI F, Wang WH, He XH, Chen B, et al
    Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.
    Int J Radiat Oncol Biol Phys. 2018;102:61-70.
    PubMed     Abstract available


  48. BOVI JA, Schultz CJ, Mehta MP, Corn BW, et al
    Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order.
    Int J Radiat Oncol Biol Phys. 2018;102:59-60.
    PubMed    


  49. PINNIX CC, Yahalom J, Specht L, Dabaja BS, et al
    Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;102:53-58.
    PubMed    


    July 2018
  50. TSANG RW, Campbell BA, Goda JS, Kelsey CR, et al
    Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;101:794-808.
    PubMed     Abstract available


  51. WONG JYC, Filippi AR, Dabaja BS, Yahalom J, et al
    Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).
    Int J Radiat Oncol Biol Phys. 2018;101:521-529.
    PubMed     Abstract available


    April 2018
  52. PARZUCHOWSKI A, Bush R, Pei Q, Friedman DL, et al
    Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.
    Int J Radiat Oncol Biol Phys. 2018;100:1119-1125.
    PubMed     Abstract available


  53. CONSTINE LS, Yahalom J, Ng AK, Hodgson DC, et al
    The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;100:1100-1118.
    PubMed     Abstract available


  54. TUMATI V, Trivedi L, Li HC, Patel P, et al
    Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:1126-1132.
    PubMed     Abstract available


    March 2018
  55. PINNIX CC, Cella L, Andraos TY, Ayoub Z, et al
    Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Mar 14. pii: S0360-3016(18)30495.
    PubMed     Abstract available


  56. NG AK, Yahalom J, Goda JS, Constine LS, et al
    Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;100:652-669.
    PubMed     Abstract available


  57. RANA S, Holland J
    Coping With Knife: Postoperative Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2018;100:547-548.
    PubMed    


  58. MARQUEZ C
    Observe, and Keep Chemotherapy Up the Sleeve.
    Int J Radiat Oncol Biol Phys. 2018;100:550.
    PubMed    


  59. SANGHVI P
    Involved-Site Radiation to Maximize Control.
    Int J Radiat Oncol Biol Phys. 2018;100:549.
    PubMed    


  60. KALLAM A, Armitage JO
    Watch and Wait, Salvage Later.
    Int J Radiat Oncol Biol Phys. 2018;100:549-550.
    PubMed    


    January 2018
  61. MILGROM SA, Pinnix CC, Chi TL, Vu TH, et al
    Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Jan 6. pii: S0360-3016(18)30003.
    PubMed     Abstract available


    October 2017
  62. THOMAS J, Ferme C, Noordijk EM, Morschhauser F, et al
    Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2017 Oct 27. pii: S0360-3016(17)33984.
    PubMed     Abstract available


  63. PATEL CG, Michaelson E, Chen YH, Silver B, et al
    Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2017 Oct 5. pii: S0360-3016(17)33954.
    PubMed     Abstract available


  64. NANDA R, Flampouri S, Mendenhall NP, Indelicato DJ, et al
    Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;99:494-497.
    PubMed    


    September 2017
  65. ARISTOPHANOUS M, Chi PM, Kao J, Williamson R, et al
    Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins.
    Int J Radiat Oncol Biol Phys. 2017 Sep 25. pii: S0360-3016(17)33936.
    PubMed     Abstract available


  66. TSENG YD, Cutter DJ, Plastaras JP, Parikh RR, et al
    Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017 Sep 21. pii: S0360-3016(17)30901.
    PubMed    


  67. WILKE C, Cao Q, Dusenbery KE, Bachanova V, et al
    Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;99:94-102.
    PubMed     Abstract available


  68. CHANG JY, Zhang X, Knopf A, Li H, et al
    Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017;99:41-50.
    PubMed     Abstract available


    August 2017
  69. MELCHERS RC, Willemze R, Daniels LA, Neelis KJ, et al
    Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
    Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33721.
    PubMed     Abstract available


  70. HAHN E, Jiang H, Ng A, Bashir S, et al
    Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
    Int J Radiat Oncol Biol Phys. 2017;98:1116-1123.
    PubMed     Abstract available


    July 2017
  71. KRUL IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, et al
    Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Int J Radiat Oncol Biol Phys. 2017 Jul 18. pii: S0360-3016(17)33598.
    PubMed     Abstract available


    June 2017
  72. MORRIS S, Scarisbrick J, Frew J, Irwin C, et al
    The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.
    Int J Radiat Oncol Biol Phys. 2017 Jun 9. pii: S0360-3016(17)31003.
    PubMed     Abstract available


    April 2017
  73. VARGO JA, Ward MC, Caudell JJ, Riaz N, et al
    A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Apr 24. pii: S0360-3016(17)30821.
    PubMed     Abstract available


  74. RIMNER A, Lovie S, Hsu M, Chelius M, et al
    Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.
    Int J Radiat Oncol Biol Phys. 2017;97:1066-1076.
    PubMed     Abstract available


    February 2017
  75. EL-FAYECH C, Haddy N, Allodji RS, Veres C, et al
    Cerebrovascular Diseases in Childhood Cancer Survivors: Role of the Radiation Dose to Willis Circle Arteries.
    Int J Radiat Oncol Biol Phys. 2017;97:278-286.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: